Nephrotic Syndrome Diagnostics & Therapeutics Market Size, Share and Forecast 2021-2027
The global nephrotic syndrome diagnostics & therapeutics market is anticipated to grow at a CAGR of around 5.6% during the forecast period (2021-2027). The key factor to drive the market growth includesthe increasing prevalence of diabetes that results in increased chances of nephrotic syndrome. For instance, In the European Union, approximately 32.3 million adults were diagnosed with diabetes in 2019, up from an estimated 16.8 million adults in 2000. In 2019, it was estimated that around 24.2 million people in Europe will be having diabetes but will go undiagnosed.Since 2000, the number of men diagnosed with diabetes has more than doubled, rising from about 7.3 million in 2000 to 16.7 million in 2019. Women with diabetes have also increased significantly, from 9.5 million in 2000 to 15.6 million in 2019.
To Request
a Sample of our Report on Nephrotic Syndrome Diagnostics & Therapeutics
Market: https://www.omrglobal.com/request-sample/nephrotic-syndrome-diagnostics-therapeutics-market
Rising acquisitions, product approval, collaborations among the major
players in the market also propel the growth of the market. For instance, in
April 2019, Angion announced a partnership agreement with Nephrotic Syndrome
Study Network (NEPTUNE)in order to investigate ANG-3070. This clinical research
is based on understanding and treatment of kidney disorders.These findings of
the research will supportdetermining the inclusion requirements for a biomarker
stratified prospective clinical trial evaluating the safety and efficacy of
ANG-3070 in primary Focal segmental glomerulosclerosis (FSGS) patients,
ensuring that the most likely patients benefit from treatment.
Market Coverage
·
The market
number available for – 2020-2027
·
Base year-
2020
·
Forecast
period- 2021-2027
Segment Covered-
·
By
Diagnosis Test
·
By
Treatment
Regions Covered-
·
North
America
·
Europe
·
Asia-Pacific
·
Rest of
the World
·
Competitive
Landscape-
(Get 15% Discount on Buying this
Report)
A
full Report of Nephrotic Syndrome Diagnostics & Therapeutics Market is
Available at: https://www.omrglobal.com/industry-reports/nephrotic-syndrome-diagnostics-therapeutics-market
Global
Nephrotic Syndrome Diagnostics & Therapeutics Market Report Segment
By Diagnosis Tests
·
Urinalysis
·
Blood Tests
·
Kidney Biopsy
·
Others (CT Scan, Renal
Ultra-Sonography)
By Treatment
·
Blood Pressure Lowering
Medications
·
Angiotensin-Converting Enzyme
(ACE) Inhibitors
·
Angiotensin Receptor Blockers
(ARBs)
·
Others (Renin Inhibitors and
Benazepril)
·
Immune System-Suppressing
Medications
·
Cholesterol-Reducing
Medications
·
Others (Blood Thinners)
Global Nephrotic Syndrome Diagnostics & Therapeutics Market
Report Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the
World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1.
We cover more than 15 major industries, further segmented into more than
90 sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/nephrotic-syndrome-diagnostics-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment